EU regulator calls for more antibiotic research

2010-12-15T11:30:32Z

LONDON (Reuters) - Drug companies are failing to put their research dollars into antibiotics and other key areas of unmet medical need, highlighting a mismatch between the hunt for profits and public health, Europe's top health regulator said.

Thomas Lonngren, outgoing head of the

EU steps up generic pharma anti-trust probe

2010-12-03T16:30:32Z

Europe stepped up action against drug companies snarling up the entry of cheaper generic medicines onto markets, announcing Friday spot inspections confirmed by British No.2 AstraZeneca.

A spokeswoman for Britain's second biggest drugmaker by sales after market leader Reuters) - Meat and milk from cloned cattle show no difference in composition from that of traditionally bred cows and so are unlikely to pose a food safety risk, an advisory committee to Britain's food safety regulator said.

The Advisory Comm...

Cloned meat and milk are not safety risks, say scientists

2010-11-29T15:00:32Z

...

Teva Beats on Higher Revenue, Maintains Guidance

2010-11-29T14:48:30Z

...

Interferon beta-1a

2010-11-30T13:10:53Z

...

How to find pharmacy technician jobs

2010-11-29T15:30:16Z

...

Docosanol

2010-11-30T13:09:43Z

...

Career profiles: Pharmacist

2010-11-29T15:31:56Z

...

The best trade magazines for entrepreneurs in biotechnology

2010-11-04T15:10:31Z

...

Novo Nordisk Profits Soar in Q3, Lifts Outlook

2010-10-27T09:03:45Z

...

Novo Nordisk profits soar in Q3, lifts outlook

2010-10-27T02:00:09Z

Danish drug maker Novo Nordisk A/S, the world's top producer of insulin, said Wednesday third-quarter profits soared 30 percent due to a sharp rise in sales, and raised its outlook for the full year.

Novo Nordisk reported a net profit of 3.6 billion kroner ($671 million), up from 2.8 billion kroner in the same period a year earlier.

Quarterly sales rose 25 percent to 15.6 billion kroner from 12.5 billion kroner. Sa...

ExonHit Announces Termination of Agreement to Acquire RedPath

2010-10-26T20:19:24Z

...

Why are there so many more today who are overweight?

2010-11-03T09:42:12Z

...

DNA FREE Event and Magnetic Products Information

2010-11-03T01:45:49Z

...

Advanced Cell Technology To Present Today at 18th Annual BioPartnering Europe Conference

2010-10-11T15:24:48Z

...

Spiriva as good as Serevent in asthma study

2010-09-21T13:07:39Z

...

New Report Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) By MarketsandMarkets

2010-10-06T03:32:26Z

Bioinformatics has gained high importance due to its ability to facilitate rapid clinical research, and also due to its various applications such as gene therapy and molecular science. Bioinformatics uses information technology, statistics, and algorithms to integrate biological data. Pharmaceutical companies are now adopting automated technologies to manufacture effective therapies and drugs due to increasing concerns about drug safety and the stringent regulations that govern clinical trial...

Big Pharma Looks to Biotech for Innovation

2010-09-13T10:20:07Z

...

What Are Barriers to Entry?

2010-11-05T09:45:47Z

...

Astra's Brilinta wins early backing in guidelines

2010-08-29T08:30:16Z

STOCKHOLM (Reuters) - AstraZeneca's new blood-thinning drug Brilinta has been given a class 1 recommendation as a treatment option under European medical guidelines, even though it has yet to be approved for sale.

New

Cereplast (NASDAQ:CERP): New Deal is Nice Bump in Qtrly Rev

2010-09-10T02:49:15Z

Cereplast (NASDAQ:CERP) a leading manufacturer of proprietary bio-based, compostable and sustainable plastics, announced today that it has entered into a multi-million dollar contract with RI.ME. Masterbatch S.r.l., ("RI.ME.") based in Mozzate (CO), Italy, to supply bioplastic resins for use in its masterbatch process for adding colorant to bulk, uncolored resins. The new agreement supports RI.ME.'s commitment to offering its customers sustainable, environmental solutions in the design and pr...

New Report on "Spain In Vitro Diagnostics Market Outlook to 2016" added in Vision Shopsters

2010-10-06T01:57:06Z

New report, ""Spain In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Spain In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories ? clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares dat...

New Report on "Italy In Vitro Diagnostics Market Outlook to 2016" added in Vision Shopsters

2010-10-06T01:57:06Z

New report, "Italy In Vitro Diagnostics Market Outlook to 2016" provides key market data on the Italy In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories ? clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data...

Commercial Insight: Antihormonal Cancer Therapies - Leading brands strive to minimize generic sales erosion now available at ReportsandReports

2010-09-09T20:08:21Z

Introduction

Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the antihormonal therapy cancer brands generated sales of about $7.0 billion in the seven major pharmaceutical markets in 2009.

Scope

* In-depth analysis of the current and futur...

Europe Is Crazy About (Cloned) Food

2010-11-02T12:25:36Z

...

Teva completes buyout of German drugmaker

2010-08-10T05:16:02Z

Teva closes $4.95B deal for German drugmaker Ratiopharm, broadens footprint in Europe

Teva Pharmaceutical has solidified operations further in Europe, announcing Tuesday that it completed a $4.95 billion buyout of German drugmaker Ratiopharm.

Teva is the...

Teva Completes Acquisition of ratiopharm

2010-09-11T13:13:14Z

...

A Changing Pharma Landscape: Three ETFs Covering the Sector

2010-11-02T12:11:45Z

...

Cloned cattle investigation stirs row in Britain

2010-08-05T04:15:27Z

Britain faced fresh questions over its food standards regime on Thursday after it emerged that meat from two offspring of a cloned cow had entered the food chain.

The two bulls whose meat was eaten by unwitting members of the public were among eight cattle conceived using embryos harvested from a cloned cow in the United States.

It is thought there may be more...

Cow clone may have over 100 descendants in Britain

2010-10-22T10:17:12Z

A cloned cow whose offspring's meat entered the British food chain may have more than 100 descendants in the country, records suggested Thursday, amid fears about their spread into the food system.

Three cattle born from the American clone had produced 97 calves, according to details on the website of Holstein UK, the body responsible for registering all pedigree cows and bulls on farms.

The news came after food safety of...

Cow clone may have over 100 descendants

2010-10-22T10:17:12Z

A cloned cow whose offspring's meat entered the British food chain may have more than 100 descendants in the country, records suggested Thursday, amid fears about their spread into the food system.

Three cattle born from the American clone had produced 97 calves, according to details on the website of Holstein UK, the body responsible for registering all pedigree cows and bulls on farms.

The news came after food safety of...

Britons fret as meat from cloned cow offspring eaten

2010-08-04T11:16:24Z

LONDON (Reuters Life!) - Britain's food watchdog said it had found that meat from the offspring of a cloned cow had entered the UK food chain and had been eaten, stirring controversy over whether such products are ethical.

The Food Standards Agency (FSA) said that under European rules,...

Meat from cloned cow's offspring eaten in Britain: officials

2010-08-04T10:15:38Z

Meat from two bulls which were the offspring of a cloned cow have entered the food chain in Britain, officials admitted Wednesday, as they continued to investigate further possible breaches.

The Food Standards Agency (FSA) said that meat from two bulls, Parable and Dundee Paratrooper, "will have been eaten".

The animals were among eight cattle ...

Cloned cow offspring meat 'eaten in Britain'

2010-08-04T06:15:34Z

Meat from a bull which was the offspring of a cloned cow has entered the food chain in Britain, officials admitted Wednesday, as fears grew of further possible breaches.

The controversy follows a Food Standards Agency (FSA) announcement earlier this week of a probe following a newspaper report that milk from the offspring of a cloned cow had gone on ...

NicOx to Close US Headquarters

2010-11-02T12:39:46Z

...

Cloned cow offspring meat in British food chain: officials

2010-08-03T15:31:38Z

British food safety officials said Tuesday that meat from the offspring of a cloned cow had entered the country's food chain last year.

The Food Standards Agency (FSA) made the discovery as it probed a report that milk from the offspring of a cloned cow had been put on sale for public consumption.

As part of this investigation, officials identified two bulls born in Britain are to investigate a claim that milk from the offspring of a cloned cow was on sale for public consumption, they said Monday.

The disclosure has provoked concern among some farming campaigners, and the Food Standards Agency (FSA) is set to investigate a report in Friday's

Food agency probes cloned cow milk claim

2010-08-02T09:15:25Z

Food safety officials in Britain are to investigate a claim that milk from the offspring of a cloned cow was on sale for public consumption, they said Monday.

The disclosure has provoked concern among some farming campaigners, and the Food Standards Agency (FSA) is set to investigate a report in Friday's

Are cloned steak and milk on European menus?

2010-11-02T13:11:07Z

...

Health Care Stocks Hospitalized, But Recovering

2010-11-02T12:24:48Z

...

The Russian Pharmaceutical Market Outlook to 2014: Policy environment, market structure, competitive landscape, growth opportunities

2010-10-05T17:39:12Z

Russia's well educated and low cost workforce is one of the main attraction for investors all over the world. According to recent statistics, Russia's population (which is currently about 141m) is steadily declining at a rate of around 0.4%. Thus, the government is trying to remedy this through several immigration policies and federal programs such as stimulating birth rates and reducing mortality.
Russia has been one of the fastest growing emerging pharmaceutical markets in the world i...

Sanofi-Aventis, Novalar Request Oraverse Approval

2010-11-02T12:39:32Z

...

Sanofi-Aventis, Novalar request OraVerse approval

2010-07-15T10:00:49Z

Sanofi-Aventis and Novalar seek approval of anesthesia reversal drug in 5 European countries

Sanofi-Aventis and Novalar Pharmaceuticals Inc. said they filed for approval of OraVerse, which is designed to reverse numbness, in five of the largest markets in Europe.

...

Former Pfizer Senior Vice President Named CEO of Berlin Pharmaceutical Industry in a Partnership to Diversify and Expand Company Business in Asia

2010-11-02T12:39:31Z

...

Upcoming Programme of Events

2010-11-02T15:35:49Z

...

PHARMACEUTICALS ampFINE CHEMICALS

2010-11-02T15:34:16Z

...

Unexpected Expression Pattern of TetracyclineRegulated Transgenes in Mice

2010-11-02T15:28:20Z

...

Bioplastics go mainstream

2010-11-02T15:24:43Z

...

Global RD spending still buoyant

2010-11-02T15:23:28Z

...

Action will be needed to boost UK biotech

2010-11-02T15:23:31Z

...

Manslaughter Act will put companies in spotlight

2010-11-02T15:14:56Z

...

Huntsworth wins panEuropean drug brief

2010-11-02T15:12:28Z

...

Cutting Drug Prices Can Hamper Development of New Medicines, Shows New Study By ESMT Competition Analysis

2010-11-02T12:39:25Z

...

Cutting drug prices hampers new development: study

2010-07-01T12:30:14Z

LONDON (Reuters) - Cutting pharmaceutical prices in the way European governments are doing now will severely reduce the number of new drugs making it to market, according to a study by a Berlin-based business group.

A report by the AstraZeneca soared by more than 10 percent in London on Wednesday, after the company won a key US ruling over its cholesterol drug Crestor.

The company's share price surged 10.49 percent to 3,256.01 pence in morning deals on the London stock market, which was show...

Under Fire from Pharma, German Institute May Lose Its Director (UPDATED)

2010-11-02T14:03:29Z

...

Forest Laboratories, Inc. and Gedeon Richter Announce Results from a Phase II Study of Radiprodil for the Treatment of Diabetic Peripheral Neuropathic Pain

2010-11-02T12:39:21Z

...

Biotech Deals Keep Flowing, From Big Pharma to Industrials

2010-11-02T12:06:14Z

...

NicOx: Presentations at EULAR congress

2010-11-02T12:39:02Z

...

Genmab announces Change in Management

2010-10-27T09:04:17Z

...

Grifols' Talecris Package Leads a Hot Week for Life Sciences Deals

2010-10-27T08:56:35Z

...

EU to allow nations to ban approved GM crops

2010-06-04T09:17:49Z

Individual EU nations will be free to ban genetically modified crops, even if they are deemed safe and approved, under rule changes being drawn up by Brussels to unblock the clearance process.

EU Health Commissioner John Dalli, in charge of the emotive dossier, will hand over plans to national capitals and the EU parliament ...

"European Pharmaceutical Directory 2010" added in Visionshopsters

2010-10-05T12:59:36Z

The market potential of the European biotechnology and pharmaceutical sector is enormous and business opportunities abound. However, unraveling the maze of who's who, and who does what is a daunting task. Here's the solution you've been looking for . . .

The new edition of The European Pharmaceutical Directory has been thoroughly researched, to bring you a completely up-to-date guide to Europe's ever-changing pharmaceutical industry.

If you need to source from, or sell to Europe...

Pharmaceuticals: Belgium Industry Guide

2010-09-22T02:48:35Z

Pharmaceuticals: Belgium Industry Guide

Datamonitor's Pharmaceuticals: Belgium Industry Guide is an essential resource for top-level data and analysis covering the Belgium Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the...

Fruit Flies Genetically Engineered to Smell Light

2010-10-27T07:11:22Z

...

Glaxo Tries a Linux Approach

2010-11-03T09:04:03Z

...

Astellas Announces New Mid-Term Management Plan

2010-10-27T06:54:35Z

...

China Biotech Week in Review: Deals Abound

2010-10-27T06:39:22Z

...

Pfizer to cut 6,000 jobs in manufacturing scaledown

2010-05-18T10:16:23Z

Pfizer, the world's biggest drug maker, said Tuesday it would eliminate 6,000 jobs worldwide as it restructures manufacturing after buying smaller rival Wyeth last year.

Pfizer said it would close eight manufacturing sites in Ireland, the United States and the US territory of P...

US drug giant Pfizer to cut 6,000 jobs

2010-05-18T08:15:42Z

Pfizer, the world's biggest drug maker, said Tuesday it would eliminate 6,000 jobs worldwide as it restructures manufacturing after buying smaller rival Wyeth last year.

Pfizer said it would close eight manufacturing sites in Ireland, the United States and the US territory of P...

Pfizer to close more plants, cut 6,000 jobs

2010-05-18T06:15:25Z

NEW YORK (Reuters) - Drugmaker Pfizer Inc will cut 6,000, or 18 percent, of jobs at its 78 manufacturing plants over the next five years as it consolidates operations following last year's purchase of smaller rival Wyeth.

The world's biggest drugmaker said it would cease operations at eight plants in Ireland, Puert...

Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network

2010-10-27T06:54:24Z

...

Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

2010-10-27T06:54:19Z

...

Pharma Continues Headlong Rush Into Branded Generics

2010-10-27T06:38:03Z

...

Pharmaceuticals: Global Industry Almanac

2010-09-21T12:37:25Z

Pharmaceuticals: Global Industry Almanac

Datamonitor''s Pharmaceuticals: Global Industry Almanac is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.( http://www.bharatbook.com/detail.asp?id=135894&am...

Medtech Brings in Life Sciences Venture Dollars

2010-10-27T06:36:10Z

...

German Pharmaceutical Industry Performance

2010-10-05T16:51:42Z

German Pharma Sector Analysis

Germany is one of the largest pharmaceutical markets in the world. Most of the pharma companies in Germany are focused on research, which has led the country to become one of the most advanced pharma markets in the world. The country's pharmaceutical market is estimated to have generated revenues of more than Euro 23 Billion (US$ 32.2 Billion) in 2009, and a consistent and strong growth is anticipated in the market for the next few years. (

Novo Nordisk Q1 profit up 23 pct, lifts outlook

2010-09-22T13:39:16Z

Danish drug maker Novo Nordisk 1st quarter profit soars 23 percent, helped by insulin sales

Danish drug maker Novo Nordisk A/S said Tuesday its first quarter profit soared 23 percent, helped by increased sales of its core insulin products.

The world's top producer of insulin said net profit in the January to March period reached 3.3 billion kroner ($595 million), up from 2.7 billion kroner in the ...

Novartis, Roche Playing Hardball With U.K.

2010-10-25T14:25:53Z

...

(4/2010) RTI Expands Health Solutions To Sweden

2010-10-27T08:17:41Z

...

Distribution On The Pharmaceutical Market In Central Europe 2010

2010-10-05T13:06:22Z

Distribution on the pharmaceutical market in Central Europe 2010

Comparative analysis of Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria

Distribution in the pharmaceutical market in Central Europe 2010 provides an in-depth analysis of distribution in the pharmaceutical sector in six Central European countries including Poland, Hungary, Romania, Czech Republic, Slovakia and Bulgaria. ( Atlanta Hawks guard Jamal Crawford,left, shoots over Sacramento Kings guard Beno Udrih, of Slovenia during the first half of an ...

Blue Jackets Coyotes Hockey

2011-01-04T21:01:31Z

Columbus Blue Jackets' R.J. Umberger (18) scores a goal against Phoenix Coyotes' Ilya Bryzgalov, of Russia, during the second period of an New Jersey Devils' Andy Greene (6) and Minnesota Wild's Martin Havlat (24), of the Czech Republic, compete for the puck during the first period of an Italy's Manuela Moelgg competes during the first run of an alpine ski women's World Cup slalom event, in Zagreb, Tuesday, Jan. 4, 2011. (AP Photo/Darko Bandic)

Russia Schwarzenegger

2011-01-04T09:32:15Z

FILE - In this Monday, Oct. 11, 2010 file photo, Russian President Dmitry Medvedev, right, invites then California Gov. Arnold Schwarzenegger for a ride in his vintage car, a Soviet built Chaika luxury car, during their meeting in the Gorki residence outside Moscow, Russia. The Russian president and the Terminator are tweeting, and m...

News on Europe

Three European companies douse hopes for new drugs

Analysis: Europe's crisis spells more pain for drugmakers

Novartis slashes 2,000 jobs despite higher earnings

Novartis to cut 2,000 jobs to save annual $200 million

EU sets out tough rules on medicines information

NICE seen at heart of new UK drug pricing system

Top court rejects generic drug labeling suits

EU regulator calls for more antibiotic research

EU steps up generic pharma anti-trust probe

Cloned meat and milk are not safety risks, say scientists

Teva Beats on Higher Revenue, Maintains Guidance

Interferon beta-1a

How to find pharmacy technician jobs

Docosanol

Career profiles: Pharmacist

The best trade magazines for entrepreneurs in biotechnology

Novo Nordisk Profits Soar in Q3, Lifts Outlook

Novo Nordisk profits soar in Q3, lifts outlook

ExonHit Announces Termination of Agreement to Acquire RedPath

Why are there so many more today who are overweight?

DNA FREE Event and Magnetic Products Information

Advanced Cell Technology To Present Today at 18th Annual BioPartnering Europe Conference

Spiriva as good as Serevent in asthma study

New Report Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) By MarketsandMarkets

Big Pharma Looks to Biotech for Innovation

What Are Barriers to Entry?

Astra's Brilinta wins early backing in guidelines

Cereplast (NASDAQ:CERP): New Deal is Nice Bump in Qtrly Rev

New Report on "Spain In Vitro Diagnostics Market Outlook to 2016" added in Vision Shopsters

New Report on "Italy In Vitro Diagnostics Market Outlook to 2016" added in Vision Shopsters

Commercial Insight: Antihormonal Cancer Therapies - Leading brands strive to minimize generic sales erosion now available at ReportsandReports

Europe Is Crazy About (Cloned) Food

Teva completes buyout of German drugmaker

Teva Completes Acquisition of ratiopharm

A Changing Pharma Landscape: Three ETFs Covering the Sector

Cloned cattle investigation stirs row in Britain

Cow clone may have over 100 descendants in Britain

Cow clone may have over 100 descendants

Britons fret as meat from cloned cow offspring eaten

Meat from cloned cow's offspring eaten in Britain: officials

Cloned cow offspring meat 'eaten in Britain'

NicOx to Close US Headquarters

Cloned cow offspring meat in British food chain: officials

Food agency probes cloned cow milk claim

Are cloned steak and milk on European menus?

Health Care Stocks Hospitalized, But Recovering

The Russian Pharmaceutical Market Outlook to 2014: Policy environment, market structure, competitive landscape, growth opportunities

Sanofi-Aventis, Novalar Request Oraverse Approval

Sanofi-Aventis, Novalar request OraVerse approval

Former Pfizer Senior Vice President Named CEO of Berlin Pharmaceutical Industry in a Partnership to Diversify and Expand Company Business in Asia

Upcoming Programme of Events

PHARMACEUTICALS ampFINE CHEMICALS

Unexpected Expression Pattern of TetracyclineRegulated Transgenes in Mice

Bioplastics go mainstream

Global RD spending still buoyant

Action will be needed to boost UK biotech

Manslaughter Act will put companies in spotlight

Huntsworth wins panEuropean drug brief

Cutting Drug Prices Can Hamper Development of New Medicines, Shows New Study By ESMT Competition Analysis

Cutting drug prices hampers new development: study

Under Fire from Pharma, German Institute May Lose Its Director (UPDATED)

Forest Laboratories, Inc. and Gedeon Richter Announce Results from a Phase II Study of Radiprodil for the Treatment of Diabetic Peripheral Neuropathic Pain

Biotech Deals Keep Flowing, From Big Pharma to Industrials

NicOx: Presentations at EULAR congress

Genmab announces Change in Management

Grifols' Talecris Package Leads a Hot Week for Life Sciences Deals

EU to allow nations to ban approved GM crops

"European Pharmaceutical Directory 2010" added in Visionshopsters

Pharmaceuticals: Belgium Industry Guide

Fruit Flies Genetically Engineered to Smell Light

Glaxo Tries a Linux Approach

Astellas Announces New Mid-Term Management Plan

China Biotech Week in Review: Deals Abound

Pfizer to cut 6,000 jobs in manufacturing scaledown

US drug giant Pfizer to cut 6,000 jobs

Pfizer to close more plants, cut 6,000 jobs

Pfizer Global Manufacturing Announces Plans to Reconfigure Its Global Plant Network

Teva Provides Update on Talampanel for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Pharma Continues Headlong Rush Into Branded Generics